TY  - JOUR

T1  - Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer

JO  - Trials

PY  - 2013/11/01

AU  - Gregory W

AU  - Marshall H

AU  - Cameron D

AU  - Twelves C

AU  - Bell R

AU  - Coleman R

ED  - 

DO  - DOI: 10.1186/1745-6215-14-s1-o120

PB  - Springer Science and Business Media LLC

VL  - 14

IS  - S1

Y2  - 2025/10/10

ER  -